The biotech firm will issue over 12 million shares at $2.82 each and pre-funded warrants for an additional 1.5 million shares at $2.819 each. Gilead Sciences, Inc. (NASDAQ: GILD ), among other new and existing investors like Samsara BioCapital and Rock Springs Capital, participated in this round of funding.